IKT

1.3201.54%
RF

Roberto Francesco Bellini

Independent Director

Mr. Roberto Francesco Bellini is Director of Congruence Therapeutics Inc. Mr. Bellini was Chairman of Inhibikase Therapeutics, Inc. from October 21, 2024 until February 14, 2025 and serves as its Independent Director since October 21, 2024. Mr. Bellini has been the Chief Executive Officer and President of BELLUS Health Inc, since January 1, 2010. Mr. Bellini served as an Executive Vice President of Picchio Pharma Inc. until January 1, 2010. He served as a Vice President of Business Development at BELLUS Health Inc. from June 04, 2009 to January 01, 2010. He has been a Director at BELLUS Health Inc. since 2009. Mr. Bellini served as a Director of Thallion Pharmaceuticals, Inc., from March 2007 to April 24, 2013. He holds a Bachelor of Science in Biochemistry from McGill University. Mr. Bellini serves as a Managing Partner at BSQUARED Capital Inc. since 2023.Directorhas B.S. in Biochemistry from McGill University.

Positions